Saturday, December 31, 2022

Making the hospital price transparency rule a reality on its two-year anniversary - The Hill

The views expressed by contributors are their own and not the view of The Hill

Stethoscope and money.
iStock

Having hospitals disclose prices for treatments up front could allow consumers to choose quality care at the price they can afford.

New Year’s Day marks the second anniversary of a federal hospital price transparency rule that has the potential to substantially lower outrageous healthcare costs burdening patients, workers, businesses, and taxpayers. The Centers for Medicaid and Medicare Services recently announced the nation spent $4.3 trillion on healthcare in 2021, nearly 20 percent of GDP and almost two times the developed-world average. The Biden administration can mark this occasion by committing to robustly enforce the rule to turn it into a reality for American healthcare consumers. 

The rule addresses the root of exorbitant hospital prices: hospitals’ opaque charging practices that blind consumers to prices, then blindside them with inflated bills they often never would have agreed to if prices were known upfront. It requires hospitals to publish their discounted cash prices and negotiated insurance rates by health plan. Armed with this information, consumers can survey well-documented wide price variations for the same care, even at the same hospital, to avoid price gouging and access care at fair market rates. 

Robust price transparency can hold hospitals accountable for egregious overcharging such as $5,000 MRIs and $100,000 knee surgeries that cost $250 and $18,000 at cash-based centers, respectively. Employers and unions knowing pricing data will allow them to benefit from competition. Price discovery will usher in quality transparency. 

Consider the union SEIU 32BJ, which saved $30 million on its health plan by shopping for care. It recently dropped New York-Presbyterian Hospital from its health plan after analyzing its claims data and determining the hospital was price-gouging its members. For example, the hospital billed the plan an average of $10,368 for outpatient colonoscopies versus $2,185 at the city’s public hospitals. Hospital price transparency can make it easier for other employers and unions to follow in SEIU 32BJ’s footsteps and significantly reduce healthcare costs. 

Unfortunately, the price transparency rule has been marred by widespread hospital noncompliance.

A recent study by PatientRightsAdvocate.org finds that only 16 percent of hospitals nationwide are following it. Most are not publishing their prices broken down by health insurer and plan as required, and some post no prices at all. 

By refusing to comply, hospitals are perpetuating a pricing scam that has saddled 100 million Americans with healthcare debt. This patient misery funds hospital private equity. The nation’s “nonprofit” hospitals are sitting on more than $283 billion in financial assets they invest Wall Street-style to generate even higher returns. HCA Healthcare, the nation’s largest private healthcare system, made $7 billion in profits in 2021. 

CMS has assisted hospitals by choosing not to enforce the rule robustly. It has issued financial penalties on only two hospitals out of the thousands nationwide that are noncompliant. Yet even this meager response indicates that enforcement works. The two fined hospitals quickly became compliant and posted exemplary price files. 

At a conference earlier this month, CMS Administrator Chiquita Brooks-LaSure was non-transparent about future enforcement, stating: “We have a lot of priorities, and the things that we will do in terms of enforcement always are ongoing and not things that we share.” 

This lack of resolve is out of step with the American public. According to a new Kaiser Family Foundation poll released last week, 95 percent of Americans want policymakers to make healthcare price transparency a key priority — more than any other proposed healthcare reform. 

The two-year anniversary of the hospital price transparency rule is an occasion for the Biden administration to stand up for American healthcare consumers and step up to properly enforce the rule. Doing so can generate a consumer revolution that ushers in a functional, competitive healthcare marketplace that stops hospital overcharging and reverses outrageous national health expenditures.

Cynthia A. Fisher is founder and chair of PatientRightsAdvocate.org

Tags Biden Centers for Medicaid and Medicare Services Cost of Health Care Health care costs Health care in the United States health care price transparency healthcare costs healthcare debt hospital price transparency lowering health care costs medical price transparency Price transparency U.S. health care costs

Adblock test (Why?)



from "price" - Google News https://ift.tt/NLeKQ36
via IFTTT

Exclusive: Drugmakers to raise prices on at least 350 drugs in U.S. in January - Reuters

NEW YORK, Dec 30 (Reuters) - Drugmakers including Pfizer Inc (PFE.N), GlaxoSmithKline PLC (GSK.L), Bristol Myers Squibb (BMY.N), AstraZeneca PLC (AZN.L) and Sanofi SA (SASY.PA) plan to raise prices in the United States on more than 350 unique drugs in early January, according to data analyzed by healthcare research firm 3 Axis Advisors.

The increases are expected to come as the pharmaceutical industry prepares for the Biden Administration's Inflation Reduction Act (IRA), which allows the government's Medicare health program to negotiate prices directly for some drugs starting in 2026. The industry is also contending with inflation and supply chain constraints that have led to higher manufacturing costs.

The increases are on list prices, which do not include rebates to pharmacy benefit managers and other discounts.

In 2022, drugmakers raised prices on more than 1,400 drugs according to data published by 46brooklyn, a drug pricing non-profit that is related to 3 Axis. That is the most increases since 2015.

The median drug price increase was 4.9% last year, while the average increase was 6.4%, according to 46brooklyn. Both figures are lower than inflation rates in the United States.

Drugmakers largely have kept increases at 10% or below - an industry practice followed by many big drugmakers since they came under fire for too many price hikes in the middle of the last decade.

Antonio Ciaccia, president of 3 Axis, said that drugmakers have focused on launching their drugs at higher prices because of the attention paid to annual price increases. The IRA should further this dynamic, he said.

"Drug makers have to take a harder look at calibrating those launch prices out of the gate ... so they don't box themselves into the point where in the future, they can't price increase their way back into profitability," he said.

More drug prices are likely to be announced over the course of January - historically the biggest month for drugmakers to raise prices.

To date, Pfizer announced the most increases, with prices rising on 89 unique drug brands, and an additional increase on 10 drug brands at its Hospira arm.

That was followed by GSK, with planned increases so far on 26 unique drugs, including nearly a 7% increase on its popular shingles vaccine Shingrix.

GSK was not immediately available for comment.

Notable increases expected include 9% price hikes on Bristol Myers Squibb's (BMY.N) personalized CAR-T cell therapies Abecma and Breyanzi, both of which were already more than $400,000 for the blood cancer treatments.

A company spokesperson said there were several driving factors in increasing the list price of the two CAR-T cell therapies, including the rate of inflation, the value of the therapies, and the personalized nature of the CAR-T manufacturing process.

Increases for Pfizer include a 6% rise on the cost of Xeljanz, a treatment for autoimmune diseases including rheumatoid arthritis and ulcerative colitis, and 7.9% increases on cancer drugs Ibrance and Xalkori.

A Pfizer spokesperson said in an email that the company's average list prices for drugs and vaccines in 2023 are well below overall inflation at approximately 3.6%, noting that the increases are needed to support investments in drug discovery.

Pfizer noted that net prices - those the company actually receives for its drugs - have fallen in the past four years because of higher rebates and discounts paid to insurance companies and pharmacy benefit managers.

AstraZeneca is set to raise prices in the 3% range on blood cancer treatment Calquence, non-small cell lung cancer drug Tagrisso and asthma treatment Fasenra.

"AstraZeneca has always taken a thoughtful approach to pricing, and we continue to do so, considering many factors," said company spokesman Brendan McEvoy.

In addition to significant R&D investments, McEvoy said AstraZeneca considers clinical value, size of patient population, government/payer coverage requirements, patient affordability, competition and other market conditions.

Sanofi plans to raise prices on 14 of its drugs or vaccines.

A Sanofi spokesperson said the drugmaker's 2023 pricing actions are consistent with its approach to responsible pricing, adherence to government policies, and the need to respond to evolving trends in the marketplace.

Reporting by Michael Erman and Julie Steenhuysen; editing by Diane Craft

Our Standards: The Thomson Reuters Trust Principles.

Adblock test (Why?)



from "price" - Google News https://ift.tt/lzTax4h
via IFTTT

Friday, December 30, 2022

Abendroth-Fortel Adds Editorial Entry to Local Waterborne Price Assessments - Yahoo Finance

The move follows market consultation with industry participants as means of providing information and benchmark prices for the commodity markets

SINGAPORE, Dec. 30, 2022 /PRNewswire/ -- Abendroth Fortel, a leading financial services adviser and a well-reputed commodity broker aiming to provide its clients with an array of investment opportunities in the commodity markets, today announced the addition of the Editorial Entry communication tool to its Market-On-Close (MOC) price assessment process for daily national waterborne across several oil products.

Abendroth Fortel Editorial Entry is an online option that allows participants in the Market-on-Close assessment process to communicate bids, offers, and transactions directly to editors and the marketplace simultaneously. Its grid-like screen offers an easy, at-a-glance view and allows market participants to instantly respond to the bids and offers submitted. The use of the tool does not preclude communicating with editors via more traditional methods such as telephone, email, and instant messaging.

Chan Tze Yan, Abendroth Fortel Editorial Entry's Senior Managing Editor said: "Through greater transparency, and efficient data management, the addition of entry technology to the Market-On-Close process will provide enhanced efficiency and functionalities to market participants while preserving the use of existing communication channels."

The domestic Japanese waterborne assessments are modeled on the refined product assessments under which spot market prices are assessed through an independent and transparent price formation process based on the Market-on-Close (MOC) methodology.

The MOC is a structured, highly-transparent price assessment process based on the principle that price is a function of time. The MOC process in oil identifies bids, offers, and transactions by company name and results in an end-of-trading-day value.

Prices of the waterborne oil products will be assessed for several loading locations and reflect the local market close. The unit of measure and size criteria will be established in due time.

About Abendroth Fortel

Abendroth-Fortel.com is one of the leading financial services advisers and a well-reputed commodity broker. The primary aim of the firm is to provide its clients with an array of investment opportunities in the commodity markets. Abendroth Fortel provides an unparalleled range of services like commodity trading, financial advice, alternative investments, and forex trading for both local and global investors to meet their diverse requirements. The firm's professional staff is trained to handle the highest level of service for customers of all sizes and requirements. Abendroth Fortel prefers challenging tasks that allow the company to work on the edge of its capabilities.

Press Contact:

Hoi Batisah
+65 6413 0075
http://www.abendroth-fortel.com/

Cision
Cision

View original content to download multimedia:https://www.prnewswire.com/news-releases/abendroth-fortel-adds-editorial-entry-to-local-waterborne-price-assessments-301711506.html

SOURCE Abendroth Fortel

Adblock test (Why?)



from "price" - Google News https://ift.tt/ueUi418
via IFTTT

Abendroth-Fortel Adds Editorial Entry to Local Waterborne Price Assessments - Yahoo Finance

The move follows market consultation with industry participants as means of providing information and benchmark prices for the commodity markets

SINGAPORE, Dec. 30, 2022 /PRNewswire/ -- Abendroth Fortel, a leading financial services adviser and a well-reputed commodity broker aiming to provide its clients with an array of investment opportunities in the commodity markets, today announced the addition of the Editorial Entry communication tool to its Market-On-Close (MOC) price assessment process for daily national waterborne across several oil products.

Abendroth Fortel Editorial Entry is an online option that allows participants in the Market-on-Close assessment process to communicate bids, offers, and transactions directly to editors and the marketplace simultaneously. Its grid-like screen offers an easy, at-a-glance view and allows market participants to instantly respond to the bids and offers submitted. The use of the tool does not preclude communicating with editors via more traditional methods such as telephone, email, and instant messaging.

Chan Tze Yan, Abendroth Fortel Editorial Entry's Senior Managing Editor said: "Through greater transparency, and efficient data management, the addition of entry technology to the Market-On-Close process will provide enhanced efficiency and functionalities to market participants while preserving the use of existing communication channels."

The domestic Japanese waterborne assessments are modeled on the refined product assessments under which spot market prices are assessed through an independent and transparent price formation process based on the Market-on-Close (MOC) methodology.

The MOC is a structured, highly-transparent price assessment process based on the principle that price is a function of time. The MOC process in oil identifies bids, offers, and transactions by company name and results in an end-of-trading-day value.

Prices of the waterborne oil products will be assessed for several loading locations and reflect the local market close. The unit of measure and size criteria will be established in due time.

About Abendroth Fortel

Abendroth-Fortel.com is one of the leading financial services advisers and a well-reputed commodity broker. The primary aim of the firm is to provide its clients with an array of investment opportunities in the commodity markets. Abendroth Fortel provides an unparalleled range of services like commodity trading, financial advice, alternative investments, and forex trading for both local and global investors to meet their diverse requirements. The firm's professional staff is trained to handle the highest level of service for customers of all sizes and requirements. Abendroth Fortel prefers challenging tasks that allow the company to work on the edge of its capabilities.

Press Contact:

Hoi Batisah
+65 6413 0075
http://www.abendroth-fortel.com/

Cision
Cision

View original content to download multimedia:https://www.prnewswire.com/news-releases/abendroth-fortel-adds-editorial-entry-to-local-waterborne-price-assessments-301711506.html

SOURCE Abendroth Fortel

Adblock test (Why?)



from "price" - Google News https://ift.tt/ueUi418
via IFTTT

Gas prices had a wild ride this year, making 2023 tough to predict - CNN

New York CNN  — 

US drivers have never seen a year quite like 2022.

Wild price swings at the gas pump throughout the year make predicting prices for 2023 even more difficult.

Russia’s invasion of Ukraine and the sanctions that it sparked on Russian oil sent the price of crude soaring in February at the beginning of the conflict. And even though relatively little Russian crude oil was ever exported to US refineries, the fact that oil prices are set on global commodity markets meant that US drivers were not spared a spike in gas prices.

Prices were far more volatile throughout 2022 than they were in other recent years, both during and before the pandemic roiled oil markets.

By June, the average US gas price crossed $5 a gallon for the first time ever, hitting a record $5.02 on June 14. But after that came a prolonged slide in gas prices, prompted by a number of factors, including the release of oil from the US Strategic Petroleum Reserve, concerns about the possibility of a recession in both the US and global economies, and a surge in Covid cases that caused renewed lockdowns in Asia. By the end of the year, the national average price of a gallon of regular gas had fallen to just over $3, well below the pre-invasion price, back to the average price of late summer of 2021.

But there was not the same level of relief for the price of diesel. Diesel prices fell 20% from their peak in June, only about half the decline for gasoline during the same period. And while gasoline is cheaper than it was a year ago, diesel remains close to the pre-2022 record price set in 2008. Greater demand for North American diesel by Europe in the wake of the war in Ukraine kept diesel prices so high.

While relatively few US drivers use diesel for their private cars, it is still the fuel used by most heavy trucks, so it had an impact on the average American’s wallet. Most trucking companies charge a fuel surcharge to their customers when diesel prices increase. Because virtually all goods purchased by Americans are on a truck at some point before those purchases, that was a factor driving inflation higher.

The wild swings in oil and gasoline prices were a major factor in battered consumer confidence during the year. But those swings were not felt evenly across the nation and throughout the year. Many of the western states faced much higher gas prices because of more limited refining capacity. But there were a number of refinery accidents throughout the year that caused spikes in other regions as well. So, everyone saw wide swings in prices, though not always at the same time.

There is also the wide variation in gas taxes, from 68 cents a gallon in California to only 15 cents a gallon in Alaska. Some states temporarily halted their state gas taxes during the year in the face of high prices.

But the difference in average income in the different states meant that drivers in some of the states with relatively low prices had to work almost as many hours to buy 15 gallons of gas as those drivers in high-priced states.

For example, in Mississippi, where the hourly average wage in November was $24.52, according to the Labor Department, it took 1 hour and 41 minutes of work to earn enough to pay for 15 gallons at $2.75 a gallon at year’s end. In California, where the average price of regular was $4.38 a gallon, or about 60% more than in Mississippi, the average hourly wage of $37.61 meant that they only had to work four more minutes to buy those 15 gallons.

Adblock test (Why?)



from "price" - Google News https://ift.tt/0lBbwOg
via IFTTT

Putin attempts to undermine oil price cap as global energy markets fracture - CNBC

Russia's announcement of an oil export ban on countries that abide by a G-7 price cap is the latest sign that we've entered a new era for global energy markets, according to analysts.

But they also note it's unlikely to have a short-term impact on oil prices, with markets taking their cues from data and concrete actions rather than words.

The price cap was introduced on Dec. 5 and requires traders using Western services such as maritime routes, insurance and financing to pay no more than $60 per barrel for seaborne Russian oil. Urals crude is currently trading around $50 per barrel, according to Finnish refining firm Neste.

President Vladimir Putin's decree on Tuesday said that from Feb. 1 it would stop crude oil and oil products for five months to any nation that adhered to the cap, with a separate ban on refined oil products to come.

Dan Yergin, vice chairman of S&P Global, told "CNBC Special: Taking Stock 2023" on Tuesday that despite skepticism over whether the program would work, leaders had found a way to keep oil flowing into the market while reducing Russian oil revenue.

But as a result, he said, we now have a "divided, more politically charged oil market."

"For the last 30 years, since the collapse of the Soviet Union, we've had a global market in which oil has pretty much moved around based on the economics, exceptions were Iran and Venezuela."

"But now we have what I call a partitioned oil market in which Russian oil can no longer go to its largest market, which is Europe, and the markets have been divided and that oil is now flowing east."

European countries have been scrambling to find alternative sources of oil and gas and new energy security solutions following Russia's unprovoked invasion of Ukraine in February. The EU got 14.4% of its petroleum oils from Russia in the third quarter of 2022, down 10.5 percentage points year on year, as it increased imports from the U.S., Norway, Saudi Arabia and Iraq.

On Wednesday, a German government spokesperson told Reuters that Moscow's ban would have "no practical significance" for its economy, which is Europe's largest.

Sophie Lund-Yates, lead equity analyst at Hargreaves Lansdown, said the ban would "add fuel to the anxieties around supply." Coming just as China's reopening is set to increase oil demand, crude prices are likely to remain elevated, she told CNBC by email.

However, she added: "To some extent, the export ban will have been priced in already – Russia readily applying pressure to countries which enforce unhelpful policies isn't a new or unexpected tactic. The shock in the oil price that we've seen today isn't as bad as it could have been and is likely to calm down, at least partly, in the coming weeks."

Bill Weatherburn, commodities economist at Capital Economics, agreed the immediate market impact would be limited since the move has been threatened by Russia for some time.

He also said this would be the case because the U.S. and Europe have already banned Russian seaborne crude oil imports; and Urals crude is still trading below $60, so India and China can continue to import without falling foul of the cap.

Boom phase

Bob McNally of Rapidan Energy Group told CNBC's "Squawk Box Asia" the EU's embargo on Russian seaborne oil, the oil price cap and Russia's export ban would be the most significant factors impacting supply next year, and presented a "completely new" scenario.

He expects 2023 and subsequent years to see continued volatility in oil markets. Brent crude oil futures are currently trading around $84 per barrel, near where they started the year, but have been on a roller coaster in the mean time, approaching $140 per barrel in intraday trading in March and rising above $120 per barrel in June.

McNally believes the market is ending a roughly seven-year bust phase that was characterized by oversupply, and is in the foothills of a new multiyear boom phase that will see stronger-than-expected demand. That will play out amid big geopolitical and macroeconomic uncertainties, and OPEC+ will struggle to balance the market, he said.

With Russia remaining the world's largest oil exporter for crude and refined products combined, the effects of its new embargo could be huge.

But for now, McNally argued, markets have a "boy who cried wolf" mentality after warnings that Russian supply would be cut off in March 2022 sent prices soaring but did not materialize.

"The market is in a little bit of a complacent mood regarding Russia, saying we'll believe it when we see it," McNally said.

Russian seaborne crude oil exports are down around 24% month on month in December — "so it's starting to happen, but the market will wait till it can see it before it prices it in and reacts to it," he added.

Correction: This article has been updated to correct the day that Putin's decree was announced and the name of the CNBC show that Dan Yergin appeared on.

Disclaimer

Adblock test (Why?)



from "price" - Google News https://ift.tt/XxUr93k
via IFTTT

Thursday, December 29, 2022

Here's why egg prices surged in 2022. Those elevated costs could last into the first quarter of 2023, expert says - CNBC

D3sign | Moment | Getty Images

The surge in egg prices has stood out in a year when Americans saw their bills balloon across the grocery store.

Average egg prices jumped 49.1% in November compared with those a year earlier — the largest annual percentage increase among all grocery items in that period, according to the consumer price index, a barometer of inflation.

By comparison, the overarching "food at home" category was up 12%.

The increase is even more acute when measured by the cost of a dozen large, Grade A eggs, which more than doubled to $3.59 in November from $1.72 the year-earlier month, according to data from the Federal Reserve Bank of St. Louis.

Bird flu is largely to blame for rising egg prices

Those price dynamics are primarily due to the deadliest outbreak of bird flu in U.S. history, which has killed millions of egg-laying hens this year, according to economists.

"A lot of things are up since 2020," Bill Lapp, president of Advanced Economic Solutions, a consulting firm specializing in food economics, previously told CNBC. "But the recent spike is extraordinary in the shell-egg as well as egg-product markets."

About 57.8 million birds have been affected by avian flu in 2022, according to U.S. Department of Agriculture data as of Dec. 28. These figures include birds such as turkeys and ducks.

More from Personal Finance:
5 tips for reducing holiday season credit card balances
New ways to avoid a tax penalty for early IRA withdrawals
Who will lose out most if student loan forgiveness falls through

Bird flu is relatively rare in the U.S. The last bout was in 2015, when 50.5 million birds — the previous record — were affected, according to the Centers for Disease Control and Prevention.

The flu hadn't emerged in at least a decade or two prior to that, Lapp said.

Here's why this matters: Avian flu is "highly contagious," the New Jersey Department of Agriculture said in October. It's also extremely lethal: It kills 90% to 100% of chickens, often within 48 hours, according to the CDC.

Farmers generally must kill their remaining birds — not by choice but due to federal rules meant to prevent spread, Brian Moscogiuri, a global trade strategist at Eggs Unlimited, an egg supplier based in Irvine, California, previously told CNBC.

About 40 million egg-laying hens — "layers," in industry shorthand — have died this year due to avian flu, Moscogiuri said. There were 375 million total layers in the U.S. as of Dec. 1, which is down 5% from last year, according to the USDA.

Egg quantity has declined in lockstep. About 8.9 billion eggs were produced in November, down from 9.7 billion in December 2021, according to USDA data issued Dec. 20.

"It's a supply disruption, 'act of God' type stuff," Moscogiuri said. He called the situation "unprecedented."

"It's kind of happenstance that inflation is going on [more broadly] during the same period," he added.

Price pressures may be easing

Luke Sharrett/Bloomberg via Getty Images

Bird flu typically arrives during the spring migration and disappears by the summer, experts said. But this year was different; the virus reemerged in September.

In October, the USDA revised its production forecast for table eggs downward for 2023 and the remainder of 2022 following "September detections" of bird flu.

That avian flu flare-up — and its associated death toll for egg-laying hens — is running headlong into peak demand. Consumers generally buy more eggs now for holiday baking, for example, experts said.

Consumer demand for eggs has also been buoyed by a pivot away from some higher-cost proteins amid broader food inflation, the USDA suggested in an October outlook report.

Egg prices jumped 2.3% just in the month of November, and by 10.1% in October, according to the CPI.

Elevated egg prices "could last into the first quarter of 2023," Lapp said.

But price pressures appear to be easing, according to Moscogiuri. That's partly a seasonal effect, as demand naturally lets up after the holidays. It's also due to record egg prices somewhat dampening demand, he said.

"The market has now topped and spot prices are becoming increasingly negotiable," Moscogiuri said. "As the spot price falls, the market will follow and we will likely see a 25%-30% correction from current all-time highs.

"This adjustment will likely take place over the next three weeks." Any additional, large outbreaks of bird flu could disrupt this trend, he added.

Meanwhile, chicken prices have been falling

Flock of broiler chickens inside a poultry house.
Edwin Remsberg | The Image Bank | Getty Images

Perhaps counterintuitively, chicken prices have been declining in recent months, moving opposite those of eggs.

Chicken prices retreated in October and November, falling by 1.3% and 0.8%, respectively, according to CPI data.

Chickens raised for meat consumption — known as "broilers" — aren't affected by avian flu to the same extent as the "layers."

"It's two totally different styles of production, two totally different breeds of bird," Moscogiuri said.

The life cycle of a broiler is much shorter — anywhere from 5.5 weeks to nine weeks, from hatch to slaughter, according to Vencomatic Group, a poultry consulting firm.

That cycle can be upwards of 100 weeks for an egg-laying hen, Moscogiuri said. It can take about five to six months for layers just to reach full productivity, according to the USDA. The latter are therefore more susceptible to bird flu since farmers must keep them alive for longer, experts said.

Broiler quantity is also up, contributing to lower chicken prices at the grocery store.

For example, about 851 million broiler chicks hatched in October — up 5% from the prior year, the USDA said. The number in August (865 million) broke a monthly record, which had previously been set in March 2020.

Broiler "production" (measured by total pounds of meat) will rise 2% in 2023 relative to 2022, according to government data.

Despite the recent retreat, chicken prices are still up 12% compared with October 2021, according to the CPI. Higher prices for commodities such as corn and soybeans — the primary ingredients in chicken feed — have likely contributed to inflation for chicken, as well as eggs. Higher annual energy prices also factor into elevated costs for food distribution, for example.

Adblock test (Why?)



from "price" - Google News https://ift.tt/6Li1eNB
via IFTTT

Oil, Wheat, Copper and Other Commodities Will Enjoy Price Rises in 2023 - Bloomberg

[unable to retrieve full-text content]

Oil, Wheat, Copper and Other Commodities Will Enjoy Price Rises in 2023  Bloomberg

from "price" - Google News https://ift.tt/ZrElb5s
via IFTTT

Double-digit U.S. home price growth streak skids to an end - Reuters

Dec 27 (Reuters) - Annual price growth in the increasingly fragile U.S. housing market slid into the single digits in October for the first time in about two years when mortgage rates that month surged above 7% and further stifled demand, a pair of closely watched surveys showed on Tuesday.

The S&P CoreLogic Case Shiller national home price index increased by 9.2% in October, down from 10.7% in September and notching the first single-digit gain since November 2020. Meanwhile the Federal Housing Finance Agency, which oversees U.S. mortgage-finance entities Fannie Mae and Freddie Mac, said annual home price growth slowed to 9.8% in October from 11.1% in September, marking that index's first non-double-digit gain since September 2020.

On a month-over-month basis, S&P Case Shiller's index fell for a fourth straight month, while FHFA's gauge was unchanged.

"As the Federal Reserve continues to move interest rates higher, mortgage financing continues to be a headwind for home prices," Craig Lazzara, managing director at S&P DJI, said in a statement.

The housing market has suffered the most visible effects of aggressive Fed interest rate hikes that are aimed at curbing high inflation by undercutting demand in the economy. This month the Fed raised rates again by half a percentage point, capping a year that saw its benchmark rate shoot from near zero in March to between 4.25% and 4.5% now - the swiftest rates have risen since the early 1980s. Fed officials projected rates would climb further in 2023, likely topping 5%.

Reuters Graphics

Unlike other parts of the economy - many of which have yet to show a significant impact from the Fed's actions - the housing market reacts in near real-time to the jump in borrowing costs engineered by the central bank.

The 30-year fixed mortgage rate breached 7% in October for the first time since 2002, more than doubling in the span of nine months, pulling the rug out from what had been a red-hot housing market fueled by historically low borrowing costs and a rush to the suburbs during the coronavirus pandemic.

Data last week showed the combined annual sales rates of new and existing homes through November had slumped by 35% since January - among the fastest falls on record - to the slowest since late 2011. New single-family housing starts and permit issuance skidded to a two-and-a-half-year low last month as well.

While mortgage rates have retreated since early November to around 6.3% this month, according to data from Freddie Mac and the Mortgage Bankers Association, they remain nearly twice the level they were a year ago at this time and will continue to weigh on the housing sector.

Economists do not, however, see a repeat of the housing price crash witnessed in the financial crisis when prices by S&P Case Shiller's measure fell year-over-year for a full five years from March 2007 through April 2012. Unlike then, the supply of homes on the market remains extraordinarily limited and should keep a floor under house prices.

The National Association of Realtors earlier this month projected prices for existing homes - by far the largest part of the market - should remain more or less flat in 2023.

"As the Fed tightens financial conditions, the housing market will likely slow further in the coming year," LPL Financial Chief Economist Jeffrey Roach said. "However, low inventory of homes available for sale should soften the impact from rising rates and insulate the residential market from a redux of the Great Financial Crisis."

Reporting by Dan Burns; Editing by Chizu Nomiyama

Our Standards: The Thomson Reuters Trust Principles.

Adblock test (Why?)



from "price" - Google News https://ift.tt/K7IOrgj
via IFTTT

Companies' reluctance to roll back price rises poses US inflation risk - Financial Times

[unable to retrieve full-text content] Companies' reluctance to roll back price rises poses US inflation risk    Financial Times from...